pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,883 catalysts · 5,256 phase readout · 2,309 8k filing · 315 pdufa · 259 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 38 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,256
  • 8k filing2,309
  • pdufa315
  • earnings259
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07438236: Cognitive Performance and Mood After Ingestion of Dietary Supplement by University Students

Sponsor: Cooperativa de Ensino Superior, Politécnico e Universitário. Phase: NA. Conditions: Cognitive Performance, Mood, Dietary Supplement, Safety

full page →ctgov ↗
›COMPLETEDphase readoutNCT04535011: PRACT to Investigate Controlling Alcohol Related Harms in a Low-Income Setting; Emergency Department BIs in Tanzania

Sponsor: Duke University. Phase: NA. Conditions: Alcohol Use Disorder, Injury Traumatic, Trauma

full page →ctgov ↗
›RECRUITINGphase readoutNCT05508971: Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)

Sponsor: Oregon Health and Science University. Phase: NA. Conditions: Obstructive Sleep Apnea, Down Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05214092: Cortical Contributions to FFR: Post-Op Outcomes

Sponsor: University of Pittsburgh. Phase: NA. Conditions: Language

full page →ctgov ↗
›RECRUITINGphase readoutNCT06991192: ACL Reconstruction Rehabilitation With Exercise and Psychological Support

Sponsor: HealthPartners Institute. Phase: NA. Conditions: Anterior Cruciate Ligament Reconstruction Rehabilitation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07416734: RCT of HeartBot in Women

Sponsor: University of California, San Francisco. Phase: NA. Conditions: Participants Must be Women Aged 25 Years or Older, Participants Should Have no Self-reported History of Heart Disease or Stroke, Participants Should Have no Terminal Illness or Diagnosed Cognitive Impairment, Including Alzheimer's Disease, Participants Should Not be a Healthcare Professionals or Healthcare Trainees, Participants Should Not be Employed in the Healthcare Field, Participants Should Reside in the United States and be a University of California, San Francisco Health Patient, Participants Should Possess a Smartphone With an Active Data Plan or Access to Wi-Fi

full page →ctgov ↗
›RECRUITINGphase readoutNCT07220564: A Research Study Looking at How Different Doses of Study Medicine (Inno8) Work in the Body of People With Haemophilia A

Sponsor: Novo Nordisk A/S. Phase: PHASE1. Conditions: Haemophilia A

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07412509: Can 3D Modeling Enhance Patient Understanding, Education, and Surgical Outcomes in Gender Affirming Peritoneal Vaginoplasty?

Sponsor: University of Chicago. Phase: . Conditions: Vaginoplasty, Gender Dysphoria, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07191509: Effects of Tracheostomy Decannulation on Respiratory Function

Sponsor: Capital Medical University. Phase: . Conditions: Tracheostomy Decannulation

full page →ctgov ↗
›TERMINATEDphase readoutNCT04179864: A Study of Tazemetostat With Enzalutamide or Abiraterone/Prednisone in Participants With Advanced Prostate Cancer

Sponsor: Epizyme, Inc.. Phase: PHASE1. Conditions: Metastatic Prostate Cancer, Metastatic Castration-resistant Prostate Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06164951: A Study to Evaluate the Efficacy and Safety of Infigratinib in Children and Adolescents With Achondroplasia

Sponsor: QED Therapeutics, a BridgeBio company. Phase: PHASE3. Conditions: Achondroplasia

full page →ctgov ↗
›RECRUITINGphase readoutNCT07520929: Acute Sauna Session and Glucose Control

Sponsor: University of Prince Edward Island. Phase: NA. Conditions: Obesity & Overweight

full page →ctgov ↗
›COMPLETEDphase readoutNCT05906602: Motor and Neurophysiological Changes After Ischemic Conditioning in Individuals With Stroke

Sponsor: University of Illinois at Chicago. Phase: NA. Conditions: Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06385353: DVT Burden and the Risk of Post-thrombotic Syndrome

Sponsor: Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer. Phase: NA. Conditions: Postthrombotic Syndrome

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT06958731: In-plane Versus Real Time Bi-plane Single-operator Laser-assisted With a Innovative T-shaped Probe for Ultrasound-guided Internal Jugular Vein Catheterization:A Randomized Controlled Trial

Sponsor: The First Hospital of Jilin University. Phase: NA. Conditions: Catheterization, Central Venous, Ultrasound Guided

full page →ctgov ↗
›RECRUITINGphase readoutNCT07426731: Comparison of Sacral ESP Block and Dorsal Penile Nerve Block in Pediatric Hypospadias Surgery

Sponsor: Medipol University. Phase: NA. Conditions: Postoperative Pain, Hypospadias

full page →ctgov ↗
›RECRUITINGphase readoutNCT04591002: Osimertinib to Suppress the Progression of GGN(EGFR Mutation-positive)

Sponsor: Samsung Medical Center. Phase: PHASE2. Conditions: Lung Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06780202: Assessment of Medrol Dosepak to Reduce Opioid Consumption in Foot and Ankle Surgical Patients

Sponsor: Emory University. Phase: PHASE2. Conditions: Foot Injuries and Disorders, Ankle Injuries and Disorders, Achilles Tendon Injury

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07414953: A Phase Ib Study of HS-10504 Combined Therapy in NSCLC

Sponsor: Jiangsu Hansoh Pharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Lung Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT07318337: Effect of Drospirenone-Ethinyl Estradiol (20microgram vs 30 Microgram) on Free Androgen Index in PCOS

Sponsor: Mst.Sumyara Khatun. Phase: NA. Conditions: PCOS (Polycystic Ovary Syndrome)

full page →ctgov ↗
›RECRUITINGphase readoutNCT06089083: PROmOting Gynecologic Cancer Patients With Frailty to Achieve Functional Recovery

Sponsor: University of California, San Francisco. Phase: . Conditions: Malignant Female Reproductive System Neoplasm, Gynecologic Cancer, Gynecologic Neoplasm

full page →ctgov ↗
›RECRUITINGphase readoutNCT04458883: The Next Leap in Cardiac Magnetic Resonance Imaging:Cycling the Field

Sponsor: University of Aberdeen. Phase: NA. Conditions: Myocardial Infarction

full page →ctgov ↗
›RECRUITINGphase readoutNCT07321041: Effect of Delivery Time on Umbilical Cord Blood Gas Parameters in Cesarean Sections Under General and Spinal Anesthesia

Sponsor: Sisli Hamidiye Etfal Training and Research Hospital. Phase: . Conditions: Umbilical Cord Blood, Cesarean Section Surgery, General Anesthesia, Spinal Anesthesia, Blood Gas Analysis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05208905: LIFE-BTK PK Sub-study

Sponsor: Abbott Medical Devices. Phase: NA. Conditions: Critical Limb Ischemia (CLI)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05593094: A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Solid Tumors

Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Advanced Solid Tumors, HER2-positive Breast Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT06195566: Development of PI-ML Algorithm for Prediction of the Real-time Risk for Developing Pre-diabetes

Sponsor: Jelizaveta Sokolovska. Phase: . Conditions: Prediabetic State, Body Weight, Overweight or Obesity, Life Style, Healthy

full page →ctgov ↗
›TERMINATEDphase readoutNCT04258566: Electromagnetic Tracking and Optical Imaging With ICG for Hepatic Biopsies

Sponsor: National Institutes of Health Clinical Center (CC). Phase: NA. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT04534556: Wireless Nerve Stimulation Device To Enhance Recovery After Stroke

Sponsor: Baylor Research Institute. Phase: NA. Conditions: Stroke, Chronic Stroke, Upper Extremity Paresis, Ischemic Stroke, Hemorrhagic Stroke

full page →ctgov ↗
›RECRUITINGphase readoutNCT06331351: Effect of Jing Si Herbal Tea Liquid Packets on Chronic Pharyngolaryngitis

Sponsor: Dalin Tzu Chi General Hospital. Phase: NA. Conditions: Chronic Pharyngitis

full page →ctgov ↗
›RECRUITINGphase readoutNCT03462329: Patient's Pretreatment Expectations About Post-Lyme Symptoms

Sponsor: University Medical Centre Ljubljana. Phase: NA. Conditions: Erythema Migrans

full page →ctgov ↗
›COMPLETEDphase readoutNCT06558331: Quality of Postoperative Recovery (QoR-15T) in Patients Undergoing Video-Assisted Thoracoscopic Surgery (VATS)

Sponsor: Başakşehir Çam & Sakura City Hospital. Phase: NA. Conditions: Video-Assisted Thoracic Surgery

full page →ctgov ↗
›RECRUITINGphase readoutNCT06656702: Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis

Sponsor: Johns Hopkins University. Phase: EARLY_PHASE1. Conditions: Amyotrophic Lateral Sclerosis

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT07443202: Study of Lotilaner Ophthalmic Gel in Patients With Ocular Rosacea (KORE)

Sponsor: Tarsus Pharmaceuticals, Inc.. Phase: PHASE2. Conditions: Ocular Rosacea

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427602: Immediate Implant Placement and Immediate Restoration With Prefabricated Provisionals

Sponsor: University Medical Center Groningen. Phase: . Conditions: Dental Implants, Single-tooth, Immediate Dental Implant Placement, Crown

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07198945: Six Versus Twelve Month Index Follow-up After Large Colon Polyp Resection

Sponsor: Indiana University. Phase: NA. Conditions: Colon Cancer, Colon Polyp, Adenoma, Serrated Polyp, Recurrence, Local Neoplasm, Endoscopic Resection

full page →ctgov ↗
›COMPLETEDphase readoutNCT05295095: Does Positive Pressure Extubation Reduce Postoperative Desaturation?

Sponsor: University Hospital, Lille. Phase: NA. Conditions: Extubation, Postoperative Complications, Lung Ultrasound Score

full page →ctgov ↗
›COMPLETEDphase readoutNCT06249295: Postoperative Oral Cryotherapy in Sore Throat and Daily Life

Sponsor: Chung Shan Medical University. Phase: NA. Conditions: Sleep Apnea, Obstructive

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT00738439: Prospective, Multi-Center Adult Spinal Deformity Outcomes Database Registry

Sponsor: International Spine Study Group Foundation. Phase: . Conditions: Spinal Deformity

full page →ctgov ↗
›RECRUITINGphase readoutNCT06593977: Evaluation of Dynavisc in Pain Reduction Following Revision Surgery for Persistent or Recurrent Carpal Tunnel Syndrome

Sponsor: FzioMed. Phase: NA. Conditions: Carpal Tunnel Syndrome (CTS)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07303777: Efficacy, Safety, and PopPK Profile of ABP-745 in Patients With Atherosclerosis

Sponsor: Atom Therapeutics Co., Ltd. Phase: PHASE2. Conditions: Atherosclerosis Cardiovascular Disease, ASCVD, ASCVD Management

full page →ctgov ↗
›COMPLETEDphase readoutNCT07245277: Effect of Vitamin D as Adjuvant Therapy in Preterm Infants With Neonatal Sepsis

Sponsor: Universitas Padjadjaran. Phase: PHASE4. Conditions: Neonatal Sepsis, Preterm Infants

full page →ctgov ↗
›COMPLETEDphase readoutNCT03371277: Attributional Style and Parkinson's Disease

Sponsor: CHU de Reims. Phase: NA. Conditions: Parkinson's Disease

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05092412: Low-dose Radiotherapy Combined With Durvalumab, Chemotherapy(EP) in the Treatment of ES-SCLC

Sponsor: You Lu. Phase: PHASE2. Conditions: Lung Cancer, Extensive-stage Small-cell Lung Cancer, Durvalumab

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03737981: Testing the Addition of a New Anti-cancer Drug, Venetoclax, to the Usual Treatment (Ibrutinib and Obinutuzumab) in Untreated, Older Patients With Chronic Lymphocytic Leukemia

Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07313930: Gastrectomy at Low Pressure Trial - (GALPT)

Sponsor: SurgiQuest, Inc.. Phase: NA. Conditions: Pain, Postoperative

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06591130: Culturally Adapted Intervention to Prevent Self-harm in Young People With Autism

Sponsor: Pakistan Institute of Living and Learning. Phase: NA. Conditions: Autism Spectrum Disorder, Self Harm

full page →ctgov ↗
›RECRUITINGphase readoutNCT07108465: Comparative Experimental Study Between Bupivacaine and Ropivacaine Regarding Efficacy in Third Molar Removal Surgery Under General Anesthesia

Sponsor: Henrique Tedesco. Phase: EARLY_PHASE1. Conditions: Third Molars Extraction

full page →ctgov ↗
›RECRUITINGphase readoutNCT05948865: A Phase 1 Study of CPO301 in Adult Patients With Advanced or Metastatic Solid Tumors

Sponsor: Conjupro Biotherapeutics, Inc.. Phase: PHASE1. Conditions: Cancer, Cancer, Lung

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06018467: Senolytics to Improve Osteoporosis Therapy

Sponsor: Odense University Hospital. Phase: PHASE2. Conditions: Osteopenia, Osteoporosis, Age-related Bone Loss

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05577767: Does Longitudinal Nursing Follow-up Improve Smoking Cessation in Patients Referred for COPD Screening

Sponsor: Centre Hospitalier de Valence. Phase: . Conditions: COPD, Nurse's Role

full page →ctgov ↗
← prev
page 73 of 158
next →